Clinical Immunology, Neuropharmacology and Drug Development

Molecular neuropharmacology involves the study of neurons and their organic compound interactions, and receptors on neurons, with the goal of developing new medication that may treat medical specialty disorders like pain, neurodegenerative diseases, and psychological disorders (also well-known during this case as neuropsychopharmacology). There are some technical words that have got to be outlined once relating neurotransmission to receptor action.

• 
  Agonist – a molecule that binds to a receptor super molecule and activates that receptor


• 
  Competitive antagonist – a molecule that binds to a similar website on the receptor super molecule because the agonist, preventing activation of the receptor

Non-competitive antagonist – a molecule that binds to a receptor supermolecule on a unique website than that of the agonist, however causes a conformational modification within the supermolecule that doesn't permit activation.